Chang Chun High and New Technology Industry (Group) Inc.

Research Chang Chun High and New Technology Industry (Group) Inc. (000661.SZ) on Bullrun: market cap CNY 27.90B, dividend yield 0.2%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is CNY 27.90B; dividend yield is 0.2%.

Peer valuation comparison

Latest dividend yield is 0.23% versus a Healthcare sector median of 2.4% (90.4% below).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18CNY 27.90Bn/a0.2%0.16

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.16 CNY, yield 0.2%.

About Chang Chun High and New Technology Industry (Group) Inc.

Changchun High-Tech Industry (Group) Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells biopharmaceuticals and traditional Chinese medicines products in China. The company offers recombinant human growth hormone injection; recombinant human follicle stimulating hormone for injection; herpes zoster vaccines; live attenuated varicella vaccine; freeze-dried nasal spray live attenuated influenza; xueshuanxinmaining tablet; and yinhuamiyanling tablet.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Chang Chun High and New Technology Industry (Group) Inc.'s market cap?

Chang Chun High and New Technology Industry (Group) Inc.'s market capitalization is CNY 27.90B.

Does Chang Chun High and New Technology Industry (Group) Inc. pay a dividend?

Chang Chun High and New Technology Industry (Group) Inc. has a dividend yield of 0.2%.

What does Chang Chun High and New Technology Industry (Group) Inc. do?

Changchun High-Tech Industry (Group) Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells biopharmaceuticals and traditional Chinese medicines products in China. The company offers recombinant human growth hormone injection; recombinant human follicle stimulating hormone for injection; herpes zoster vaccines; live attenuated varicella vaccine; freeze-dried nasal spray live attenuated influenza; xueshuanxinmaining tablet; and yinhuamiyanling tablet. It also develops real estate properties. The company was founded in 1993 and is based in Changchun, China.